FIELD: medicine; surgery.
SUBSTANCE: 2 hours before surgery, patients are prescribed hydroxyethyldimethyldihydropyrimidine — Ximedon at a dosage of 1 gram before meals once. In the postoperative period from 1 to 7 days inclusive, 0.5 grams 3 times a day.
EFFECT: method provides reduction of inflammatory reaction, increase of immune response to surgical aggression, activation of regenerative processes which leads to prevention of pathological course of surgical wound process and development of early postoperative complications.
1 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL PRODUCT FOR OPTIMISING THE SURVIVAL OF A SILICONE IMPLANT AFTER RECONSTRUCTIVE-REPARATIVE BREAST SURGERY | 2022 |
|
RU2788259C1 |
| METHOD OF SURGICAL TREATMENT OF MAMMARY GLAND CYSTS | 2017 |
|
RU2669048C1 |
| MEDICAMENT FOR ACCEPTANCE STIMULATING OF THE MESH IMPLANT AFTER PLASTIC REPAIR OF THE VENTRAL HERNIAS | 2019 |
|
RU2712210C1 |
| METHOD FOR PREDICTION OF WOUND COMPLICATIONS DURING ORGAN-PRESERVING OPERATIONS IN PATIENTS WITH STAGE I-II BREAST CANCER, WITH TUMOR LOCALIZATION IN UPPER QUADRANTS | 2022 |
|
RU2790464C1 |
| METHOD OF TREATING MASTOPATHY | 2023 |
|
RU2819077C1 |
| METHOD FOR STIMULATING POSTOPERATIVE BREAST WOUND HEALING | 2010 |
|
RU2428198C1 |
| METHOD FOR REMOVAL OF MULTIPLE BENIGN BREAST GROWTHS THROUGH SINGLE APPROACH WITH SUBSEQUENT CORRECTION OF PTOSIS WITH HEMISPHERICAL GLANDULAR FLAP | 2023 |
|
RU2815765C1 |
| DEVICE AND METHOD FOR COMBINED APPARATUS-PHARMACOLOGICAL SEPARATION OF MUSCULAR-FASCIAL COMPONENTS OF ABDOMINAL WALL IN SURGICAL MANAGEMENT OF POSTOPERATIVE VENTRAL HERNIAS | 2021 |
|
RU2824801C2 |
| METHOD OF ORGANOSPARE SURGERY IN STAGE I-II BREAST CANCER WITH TUMOR LOCALIZATION IN UPPER EXTERNAL QUADRANT | 2022 |
|
RU2802140C1 |
| METHOD FOR SURGICAL CORRECTION OF BREAST PTOSIS | 2022 |
|
RU2780368C1 |
